Abstract
Frailty has been recognized as an important geriatric syndrome characterized by decreased functional and physiologic reserve with multi-system dysregulation, increased vulnerability to stressors, and high risk for serious adverse health outcomes. Two models have widely been utilized for screening and identifying frail older adults in many different clinical settings with numerous variations described in the literature. Frailty phenotype defines frailty as a distinct clinical syndrome meeting three or more of the five phenotypic criteria: weakness, slowness, low level of physical activity, exhaustion, and unintentional weight loss. Frailty index defines frailty as cumulative deficits identified in comprehensive geriatrics assessment. Chronic inflammation marked by elevated levels of inflammatory and immune activation markers, above and beyond age-related changes, is considered to play a key role in the pathogenesis of frailty. This chapter will provide an overview of frailty and its relationship with several molecular and cellular markers of chronic inflammation and immune activation, including interleukin-6, C-reactive protein, other pro-inflammatory molecules, as well as white blood cell and its specific subpopulations. It will also present emerging evidence for inflammatory pathway activation in frail older adults and a brief discussion about the role of chronic inflammation, directly and/or indirectly through other intermediary pathophysiologic processes, in contributing to frailty.
Similar content being viewed by others
References
Bandeen-Roche K et al (2009) Measuring systemic inflammatory regulation in older adults: evidence and utility. Rejuvenation Res 12(6):403–410
Baylis D et al (2013) Immune-endocrine biomarkers as predictors of frailty and mortality: a 10-year longitudinal study in community-dwelling older people. Age 35:963–971
Bortz WM (1993) The physics of frailty. J Am Geriatr Soc 41:1004–1008
Buta BJ, Walston JD, Godino JG et al (2016) Frailty assessment instruments: Systematic characterization of the uses and contexts of highly-cited instruments. Ageing Res Rev 26:53–61
Chaves PH et al (2005) Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: the Women’s Health and Aging Studies I and II. J Gerontol A Biol Sci Med Sci 60:729–735
Clegg A et al (2013) Frailty in elderly people. Lancet 381:752–762
Collerton J et al (2012) Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: cross-sectional findings from the Newcastle 85+ Study. Mech Ageing Dev 133(6):456–466
De MM et al (2006) Inflammation markers predicting frailty and mortality in the elderly. Exp Mol Pathol 80(3):219–227
DeFanis U, Wang G et al (2008) T-lymphocytes expressing CC chemokine receptor-5 are increased in frail older adults. J Am Geri Soc 56(5):904–908
Ershler WB (1993) Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc 41(2):76–181
Ershler WB, Keller ET (2000) Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 51:245–270
Ferrucci L et al (2002) Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc 50(12):1947–1954
Franceschi C et al (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908:244–254
Fried LP et al (2001) Frailty in Older Adults: Evidence for a Phenotype. J Gerontol A Biol Sci Med Sci 56A:M1–M11
Fried LP et al (2004) Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 59:255–263
Fried LP, Hadley EC, Walston JD et al (2005) From bedside to bench: research agenda for frailty. Sci Aging Knowl Environ 2005:e24
Fried LP et al (2009) Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment. J Gerontol A Biol Sci Med Sci 64:1049–1057
Hage FG et al (2007) C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. J Am Coll Cardiol 50(12):1115–1122
Hamaker ME et al (2012) Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. Lancet Oncol 13:e437–e444
Harris TB et al (1999) Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106(5):506–512
Hubbard RE et al (2009) Inflammation and frailty measures in older people. J Cell Mol Med 13(9B):3103–3109
Jones DM, Song X, Rockwood K (2004) Operationalizing a frailty index from a standardized comprehensive geriatric assessment. J Am Geriatr Soc 52:1929–1933
LaCroix AZ et al (2008) Statin use and incident frailty in women aged 65 years or older: prospective findings from the Women’s Health Initiative Observational Study. J Gerontol A Biol Sci Med Sci 63:369–375
Lee WJ et al (2016) Independent of IL-6, Is Associated with Prevalent Frailty in Community-Dwelling Elderly Taiwanese People. PLoS One 11(6):e0157877. https://doi.org/10.1371/journal.pone.0157877
Leng SX (2009) Association of neutrophil and monocyte counts with fraily in community-dwelling older women. Exp Gerontol 44:511–516
Leng SX, Margolick JB (2015) Understanding frailty, aging, and inflammation in HIV infection. Curr HIV/AIDS Rep 12(1):25–32
Leng S et al (2002) Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc 50:1268–1271
Leng S et al (2004a) Decreased Cell Proliferation and Altered Cytokine Production in Frail Older Adults. Aging Clin Exp Res 16:249–252
Leng SX et al (2004b) Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty. Aging Clin Exp Res 16:153–157
Leng SX et al (2005a) Baseline total and specific differential white blood cell counts and 5-year all-cause mortality in community-dwelling older women. Exp Gerontol 40(12):982–987
Leng SX et al (2005b) Total and differential white blood cell counts and their associations with circulating interleukin-6 levels in community-dwelling older women. J Gerontol Med Sci 60A:195–199
Leng SX et al (2007) Inflammation and frailty in older women. J Am Geriatr Soc 55(6):864–871
Leng SX et al (2009) White blood cell counts, insulin-like growth factor-1 levels, and frailty in community-dwelling older women. J Gerontol A Biol Sci Med Sci 64:499–502
Leng SX, Tian XP, Matteini A et al (2011a) L-6-independent association of elevated serum neopterin levels with prevalent frailty in community-dwelling older adults. Age Ageing 40(4):275–281
Leng SX et al (2011b) Relationship between cytomegalovirus (CMV) IgG serology, detectable CMV DNA in peripheral monocytes, and CMV pp65(495-503)-specific CD8+ T cells in older adults. Age (Dordr) 33(4):607–614
Leng SX et al (2011c) Association of detectable cytomegalovirus (CMV) DNA in monocytes rather than positive CMV IgG serology with elevated neopterin levels in community-dwelling older adults. Exp Gerontol 46:679–684
Li HF, Weng P et al (2014) Chronic CMV infection in older women: longitudinal comparisons of CMV DNA in peripheral monocytes, anti-CMV IgG titers, serum IL-6 levels, and CMV pp65 (NLV)-specific CD8(+) T-cell frequencies with twelve year follow-up. Exp Gerontol 54:84–89
Lipsitz LA (1992) Loss of ‘complexity’ and aging. Potential applications of fractals and chaos theory to senescence. JAMA 267:1806–1809
Lipsitz LA (2002) Dynamics of stability: the physiologic basis of functional health and frailty. J Gerontol A Biol Sci Med Sci 57:115–125
Liu R et al (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86(3):367–377
Loetscher P et al (1998) CCR5 is characteristic of Th1 lymphocytes. Nature 391(6665):344–345
Lu Y et al (2016) Inflammatory and immune markers associated with physical frailty syndrome: findings from Singapore longitudinal aging studies. Oncotarget 7(20):28783–28795
Maggio M et al (2006) Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol A Biol Sci Med Sci 61(6):575–584
Makary MA et al (2010) Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg 210:901–908
Margolick JB et al (2018) Relationship between T-cell responses to CMV, markers of inflammation, and frailty in HIV-uninfected and HIV-infected men in the Multicenter AIDS Cohort Study. J Infect Dis 218(2):249–258
Margolis KL, Manson JE et al (2005) Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women’s Health Initiative Observational Study. Arch Intern Med 165(5):500–508
Michelon E et al (2006) Vitamin and carotenoid status in older women: associations with the frailty syndrome. J Gerontol A Biol Sci Med Sci 61:600–607
Morley JE et al (2013) Frailty consensus: a call to action. J Am Med Dir Assoc 14:392–397
Newman AB et al (2001) Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci 56:M158–M166
Peters LL et al (2012) Measurement properties of the Groningen Frailty Indicator in home-dwelling and institutionalized elderly people. J Am Med Dir Assoc 13:546–551
Piggott DA et al (2015) Railty, Inflammation, and Mortality Among Persons Aging With HIV Infection and Injection Drug Use. J Gerontol A Biol Sci Med Sci 70(12):1542–1547
Puts MTE et al (2005) Endocrine and inflammatory markers as predictors of frailty. Clin Endocrinol 63:403–411
Qin S et al (1998) The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 101(4):746–754
Qu T et al (2009a) Pregulated ex vivo expression of stress-responsive inflammatory pathway genes by LPS-challenged CD14(+) monocytes in frail older adults. Mech Aging Dev 130:161–166
Qu T et al (2009b) Upregulated monocytic expression of CXC chemokine ligand 10 (CXCL-10) and its relationship with serum interleukin-6 levels in the syndrome of frailty. Cytokine 46:319–324
Reiner AP et al (2009) Peripheral blood markers of inflammation predict mortality and functional decline in high functioning community-dwelling older persons. Am J Med 122:947–954
Reuben DB et al (2002) J Am Geriatr Soc 50(4):638–644
Rockwood K, Mitnitski A (2007) Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci 62:722–727
Rockwood K, Mitnitski A (2011) Frailty defined by deficit accumulation and geriatric medicine defined by frailty. Clin Geriatr Med 27:17–26
Romero-Ortuno R et al (2010) A frailty instrument for primary care: findings from the Survey of Health, Ageing and Retirement in Europe (SHARE). BMC Geriatr 10:57
Ruggiero C et al (2007) White blood cell count and mortality in the Baltimore Longitudinal Study of Aging. J Am Coll Cardiol 49(18):1841–1850
Schmaltz HN et al (2005) Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J Am Geriatr Soc 53(5):747–754
Semba RD (2005) T cell subsets and mortality in older community-dwelling women. Exp Gerontol 40(1–2):81–87
Soysal P et al (2016) Inflammation and frailty in the elderly: A systematic review and meta-analysis. Aging Res Rev 31:1–8
Taaffe DR et al (2000) Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci 55(12):M709–M715
Tillet W et al (1930) Serological Reactions In Pneumonia with a Non-Protein Somatic Fraction of Pneumococcus. J Exp Med 52:561–571
van Abellan KG et al (2008) The I.A.N.A Task Force on frailty assessment of older people in clinical practice. J Nutr Health Aging 12:29–37
Van Epps P, Oswald D et al (2016) Frailty has a stronger association with inflammation than age in older veterans. Immun Ageing 13:27
Vasto S et al (2007) Zinc and inflammatory/immune response in aging. Ann N Y Acad Sci 1100:111–122
Visser M et al (2002) Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 57(5):M326–M332
Walston J et al (2002) Frailty and activation of the inflammation and coagulation systems with and without clinical morbidities: Results from the Cardiovascular Health Study. Arch Intern Med 162:2333–2341
Walston J, Hadley EC, Ferrucci L et al (2006) Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 54:991–1001
Wang GC et al (2010) Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study. Am J Epidemiol 171:1144–1152
Yao X et al (2011) Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults. Vaccine 29(31):5015–5021
Acknowledgments
This work was supported in part by an NIH grant R01AI108907 and funding from the Milstein Medical Asian American Partnership (MMAAP) Foundation (www.mmaapf.org) to Dr. Sean X. Leng. Dr. Haiyan Zhang is an Irma and Paul Milstein Program for Senior Health fellow supported by the MMAAP Foundation (www.mmaapf.org).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Leng, S.X., Zhang, H., Fried, L.P. (2019). Inflammatory Markers and Frailty. In: Fulop, T., Franceschi, C., Hirokawa, K., Pawelec, G. (eds) Handbook of Immunosenescence. Springer, Cham. https://doi.org/10.1007/978-3-319-64597-1_62-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-64597-1_62-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-64597-1
Online ISBN: 978-3-319-64597-1
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences